Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

412
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
412
Randomized Experiments01:13

Randomized Experiments

8.0K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.0K
Epistasis Analysis01:09

Epistasis Analysis

5.3K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.3K
Law of Independent Assortment02:03

Law of Independent Assortment

56.9K
While Mendel’s Law of Segregation states that the two alleles for one gene are separated into different gametes, a different question of how different genes are inherited remains. For example, is the gene for tall plants inherited with the gene for green peas? Mendel asked this question by experimenting with a dihybrid cross; a cross in which both parents are homozygous for two distinct traits resulting in an F1 generation that are heterozygous for both traits.
56.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.5K
Dihybrid Crosses01:18

Dihybrid Crosses

76.5K
Overview
76.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of <i>ABCB1</i> and <i>CYP2C19</i> polymorphisms with major adverse cardiovascular complications in patients taking clopidogrel.

Frontiers in cardiovascular medicine·2026
Same author

Cardiologists' perspectives on pharmacogenomics implementation in a hybrid health system: A qualitative study from the United Arab Emirates.

PloS one·2026
Same author

The diabetes exposome: interplay of environmental and genetic determinants in diabetes.

Human genomics·2026
Same author

AI-genomics synergy for drug repurposing in breast cancer: an interpretability-driven framework.

NPJ genomic medicine·2026
Same author

Correction: Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors.

Frontiers in immunology·2026
Same author

Identification of a Novel VLDLR Variant in the First Report of CAMRQ1 From Africa: Expanding the Spectrum of Cerebellar Ataxia Syndromes.

Human mutation·2026

Related Experiment Video

Updated: Sep 26, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K

Mendelian randomization in pharmacogenomics: The unforeseen potentials.

Lubna Q Khasawneh1, Zeina N Al-Mahayri1, Bassam R Ali2

  • 1Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, United Arab Emirates.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|April 16, 2022
PubMed
Summary

Mendelian randomization (MR) and pharmacogenomics (PGx) research intersect to accelerate precision medicine. Combining these methods supports generalizing PGx findings and aids drug discovery, enhancing clinical implementation.

Keywords:
Electronic health recordsInstrumental variablesInterdisciplinary researchMendelian randomizationPharmacogenomics

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K

Related Experiment Videos

Last Updated: Sep 26, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K

Area of Science:

  • Epidemiology
  • Genetics
  • Pharmacology

Background:

  • Mendelian randomization (MR) uses genetic variants to infer causal relationships between exposures and outcomes, bridging observational studies and clinical trials.
  • Pharmacogenomics (PGx) research is crucial for precision medicine, yielding validated biomarkers but facing implementation challenges.
  • The synergy between MR and PGx is increasingly recognized for advancing medical research and application.

Purpose of the Study:

  • To examine the intersection of Mendelian randomization (MR) and pharmacogenomics (PGx) research.
  • To highlight how MR can support the generalization and implementation of PGx findings.
  • To explore the collaborative potential of MR and PGx in drug discovery and precision medicine.

Main Methods:

  • Review of existing literature on Mendelian randomization and pharmacogenomics.
  • Analysis of the synergistic relationship between MR and PGx in causal inference and drug development.
  • Discussion of interdisciplinary collaboration involving PGx researchers, epidemiologists, and data scientists.

Main Results:

  • MR can provide supporting evidence for generalizing PGx findings, facilitating clinical translation.
  • PGx research offers valuable genetic variants for enhancing MR studies.
  • The combined approach accelerates the identification of new drug targets and drug repurposing.

Conclusions:

  • The intersection of MR and PGx offers a powerful framework for advancing precision medicine.
  • Interdisciplinary collaboration is key to unlocking the full potential of these combined methodologies.
  • Accelerated implementation of PGx discoveries into clinical practice is achievable through synergistic research approaches.